Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded end-point, non-inferiority trial

Yujian Wu, Xu Zhang, Xiaofei Xie et al.|American Heart Journal|2024

Cited by 7